Jessica Baker Flechtner is Chief Scientific Officer at GENOCEA BIOSCIENCES, INC. (GNCA). They have made 5 open-market trades across 1 company since 2014, most recently 2022-06-02.
CIK 0001591868
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 5 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| GNCA | 89,027 | $5K |
Shares reported on the most recent Form 4, priced at the 2022-06-03 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| GNCA | SELL | 2022-06-02 | 2022-06-03 | $0.06 | $95 | N/A | N/A | N/A |
| GNCA | SELL | 2022-05-25 | 2022-05-26 | $0.09 | $1K | N/A | N/A | N/A |
| GNCA | SELL | 2022-04-04 | 2022-04-05 | $1.25 | $2K | -66.5% | -81.8% | N/A |
| GNCA | SELL | 2022-03-16 | 2022-03-17 | $1.10 | $4K | +7.6% | -62.3% | N/A |
| GNCA | SELL · 10b5-1 | 2015-09-01 | 2015-09-03 | $11.35 | $25K | -33.5% | -0.6% | -0.6% |
| GNCA | SELL · 10b5-1 | 2015-08-03 | 2015-08-05 | $13.05 | $29K | -33.5% | -0.6% | -0.6% |
| GNCA | SELL · 10b5-1 | 2015-07-01 | 2015-07-06 | $13.92 | $31K | -33.5% | -0.6% | -0.6% |
| GNCA | SELL · 10b5-1 | 2015-06-01 | 2015-06-02 | $10.52 | $23K | -33.5% | -0.6% | -0.6% |
| GNCA | SELL · 10b5-1 | 2015-05-01 | 2015-05-04 | $10.21 | $23K | -33.5% | -0.6% | -0.6% |
| GNCA | SELL · 10b5-1 | 2015-04-01 | 2015-04-03 | $11.77 | $27K | -33.5% | -0.6% | -0.6% |
| GNCA | SELL · 10b5-1 | 2015-03-02 | 2015-03-04 | $8.50 | $32K | -33.5% | -0.6% | -0.6% |
| GNCA | SELL · 10b5-1 | 2015-01-29 | 2015-02-02 | $8.50 | $40K | -33.5% | -0.6% | -0.6% |
| GNCA | SELL | 2014-09-11 | 2014-09-15 | $12.00 | $77K | -33.5% | -0.6% | -0.6% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.